ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
6,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
6,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
6,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
6,5,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
7,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
11,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
12,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
13,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
13,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,3,Migraine,Migraine headaches,Headaches,Nerv,N
13,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
13,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
14,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
14,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
15,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
18,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
19,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
21,3,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
21,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
21,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
23,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
26,1,Dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,2,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
28,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
29,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
30,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
30,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
31,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
32,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
32,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
33,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
34,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
35,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
35,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
36,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
40,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
42,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
43,2,Electrocardiogram QRS complex prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
43,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
43,5,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
43,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
46,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
47,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
49,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
50,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
51,1,Headache,Headaches NEC,Headaches,Nerv,N
51,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
51,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
52,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
53,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
54,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
55,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
58,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
59,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
60,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
61,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
63,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
63,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
64,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
64,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
67,1,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
67,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
67,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
69,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
70,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
71,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
71,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
71,3,Headache,Headaches NEC,Headaches,Nerv,N
71,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
71,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
72,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
73,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
74,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
76,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
76,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
77,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
77,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
78,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
79,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
79,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
80,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
83,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
83,2,Headache,Headaches NEC,Headaches,Nerv,N
83,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
83,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
84,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
85,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Grey syndrome neonatal,Heart failures NEC,Heart failures,Card,N
86,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
86,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
87,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
89,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
90,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
91,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
92,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
94,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
94,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
95,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
95,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
96,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
97,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
98,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
100,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
100,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
101,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
103,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
104,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
105,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
105,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
106,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
107,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
108,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
109,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
109,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
110,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
111,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
111,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
111,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
112,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
112,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
112,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
112,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
113,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
114,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
114,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
115,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
115,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
115,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
117,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
117,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
118,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
119,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
119,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
119,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
119,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,1,Headache,Headaches NEC,Headaches,Nerv,N
120,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
120,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
120,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
121,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
121,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
121,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
122,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
122,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
123,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
125,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
125,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
127,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
128,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
128,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
131,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
131,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
132,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
133,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
134,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
135,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
135,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
136,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
137,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
138,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
138,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
138,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
138,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
139,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
139,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
139,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
140,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
140,2,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,Y
140,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
140,4,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
140,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
140,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
141,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
142,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
142,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
142,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
143,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
144,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
146,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
146,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
148,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
150,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
151,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
151,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
152,1,Headache,Headaches NEC,Headaches,Nerv,N
152,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
152,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
153,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
154,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
155,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
155,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
156,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
156,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
157,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
157,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
157,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
157,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
158,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
159,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
159,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
160,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
161,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
162,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
162,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
162,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
163,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
163,2,Headache,Headaches NEC,Headaches,Nerv,N
163,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
163,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
164,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
165,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
166,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
167,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
167,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
168,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
168,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
169,1,Deafness,Hearing losses,Hearing disorders,Ear,N
170,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
171,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
172,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
173,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
174,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
174,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
175,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
176,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
177,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
178,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
179,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
179,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
181,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
182,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
183,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
183,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
184,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
184,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
185,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
186,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
187,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
188,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
188,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
189,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
190,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
190,2,Headache,Headaches NEC,Headaches,Nerv,N
190,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
190,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
191,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
191,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
191,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
192,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
192,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
193,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
194,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
195,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
196,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
197,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
197,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
197,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
198,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
198,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
198,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
199,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
199,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
199,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
200,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
201,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
202,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
203,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
203,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
203,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
205,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
205,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
206,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
207,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
207,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
209,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
209,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
210,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
210,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
211,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
211,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
212,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
213,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
214,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
214,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
216,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
217,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
217,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
219,1,Headache,Headaches NEC,Headaches,Nerv,N
219,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
219,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
221,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
222,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
223,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
224,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
225,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
226,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
227,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
228,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
229,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
229,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
229,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
230,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
230,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
231,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
231,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
232,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
232,2,Headache,Headaches NEC,Headaches,Nerv,N
232,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
232,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
232,5,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
233,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
234,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
235,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
236,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
237,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
238,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
239,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
239,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
240,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
241,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
241,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
242,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
242,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
243,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
244,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
244,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
245,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
246,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
246,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
248,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
249,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
249,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
250,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
251,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
251,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
252,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
253,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
253,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
253,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
254,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
254,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
254,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
254,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
254,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
255,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
255,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
256,1,Deafness,Hearing losses,Hearing disorders,Ear,N
257,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
257,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
257,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
257,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
257,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
259,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
259,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
260,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
260,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
261,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
262,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
262,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
262,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
262,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
263,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
264,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
265,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
266,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
267,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
268,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
269,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
270,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
271,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
272,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
272,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
273,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
273,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
274,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
275,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
276,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
276,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
276,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
276,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
276,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
277,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
278,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
279,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
280,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
280,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
280,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
280,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
281,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
282,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
283,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
283,2,Headache,Headaches NEC,Headaches,Nerv,N
283,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
284,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
285,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
286,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
286,2,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
287,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
287,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
288,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
288,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
288,5,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
289,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
290,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
291,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
292,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
292,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
293,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
293,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
293,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
294,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
294,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
294,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
295,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
295,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
296,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
297,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
297,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,3,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
298,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
298,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
298,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
298,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
298,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
299,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
300,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
301,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
301,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
302,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
303,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
304,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
304,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
305,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
306,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
307,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
308,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
309,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
309,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
311,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
312,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
312,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
312,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
313,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
313,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
313,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
313,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
314,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
314,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
315,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
316,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
317,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
317,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
318,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
319,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
319,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
321,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
322,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
322,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
323,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
324,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
325,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
326,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
326,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
327,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
327,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
328,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
329,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
330,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
330,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
331,1,Blood creatinine,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
331,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
331,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
331,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
331,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
332,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
333,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
334,2,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
334,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
335,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
336,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
337,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
338,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
338,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
338,3,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
338,4,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
338,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
338,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
338,7,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
339,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
339,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
339,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
339,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
339,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
339,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,1,Peritoneal fluid analysis abnormal,Peritoneal fluid and membrane function analyses,Gastrointestinal investigations,Inv,N
340,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
341,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
342,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
343,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
344,1,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
344,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
345,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
345,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
346,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
347,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
348,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
349,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
350,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
351,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
352,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
353,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
353,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
353,4,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
354,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
354,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
354,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
355,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
355,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
355,3,Headache,Headaches NEC,Headaches,Nerv,N
355,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,5,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
355,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
356,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
357,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
357,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
358,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
359,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
360,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
360,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
361,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
362,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
363,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
363,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
363,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
363,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
364,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
365,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
366,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
366,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
367,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
367,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
367,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
368,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
368,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
368,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
369,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
370,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
374,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
377,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
380,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
380,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
380,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
380,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
381,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
381,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
381,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
382,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
383,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
384,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
385,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
386,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
386,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
386,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
386,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
386,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
386,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
387,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
387,2,Bursitis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
387,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
387,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
387,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
387,6,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
387,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
387,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
388,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
389,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
390,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
392,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
393,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
394,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
395,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
396,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
396,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
396,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
396,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
396,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
396,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
396,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
396,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
396,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
396,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
398,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
399,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
400,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
400,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
401,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
402,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
403,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
404,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
405,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
405,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
406,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
407,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
408,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
408,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
409,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
409,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
409,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
410,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
411,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
411,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
411,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
411,5,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
412,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
413,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
414,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
414,2,Lactobacillus infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
415,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
415,2,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
415,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
416,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
417,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
418,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
418,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
418,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
418,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
418,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
419,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
420,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
420,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
421,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
421,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
422,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
423,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
423,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
424,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
424,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
425,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
426,1,Enterococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
426,2,Haematological malignancy,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
426,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
426,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
427,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
427,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
427,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
428,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
429,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
430,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
431,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
432,2,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
432,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
432,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
433,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
433,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
433,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
434,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
434,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
434,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
434,5,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
434,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
434,7,Urinary casts,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
435,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
435,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
435,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
435,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
436,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
436,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
436,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
437,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
437,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
437,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
438,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
439,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
439,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
440,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
441,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
441,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
442,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
443,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
444,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
445,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
446,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
446,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
447,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
447,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
447,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
447,4,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
447,5,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
447,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
447,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
447,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
447,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
447,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
447,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
448,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
449,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
450,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
450,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
450,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
450,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
450,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
451,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
451,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
451,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
451,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
451,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
452,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
452,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
452,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
452,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
452,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
452,6,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
452,7,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
452,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
452,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
452,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
453,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
453,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
454,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
454,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
454,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
455,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
456,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
456,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
456,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
456,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
456,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
457,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
457,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
458,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
458,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
458,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
458,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
458,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
458,6,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
458,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
458,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
458,9,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
459,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
459,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
460,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
460,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
460,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
461,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
461,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
461,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
461,4,Headache,Headaches NEC,Headaches,Nerv,N
461,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
462,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
463,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
464,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
464,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
464,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
465,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
465,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
465,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
466,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
466,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
467,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
469,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
470,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
470,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
470,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
470,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
471,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
471,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
471,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
472,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
472,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
473,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
474,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
475,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
475,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
475,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
475,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
476,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
476,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
477,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
478,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
478,2,Postoperative wound complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
478,3,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
478,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
478,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
479,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
480,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
480,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
481,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
482,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
482,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
482,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
482,4,Tetanus,Clostridia infections,Bacterial infectious disorders,Infec,N
482,5,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
483,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
483,2,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
484,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
485,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
486,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
486,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
486,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
487,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
488,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
489,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
491,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
491,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
491,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
491,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
491,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
491,6,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
492,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
493,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
493,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
494,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
495,1,Deafness,Hearing losses,Hearing disorders,Ear,N
495,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
495,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
496,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
496,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
496,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
496,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
496,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
496,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
496,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
496,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
496,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
497,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
497,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
498,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
498,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
498,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
499,1,Tooth deposit,Dental surface disorders,Dental and gingival conditions,Gastr,N
499,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
500,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
500,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
500,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
501,1,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
501,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
501,3,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
501,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
501,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
503,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
503,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
504,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
504,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
505,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
506,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
507,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
507,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
508,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
509,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
510,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
511,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
511,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
511,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
511,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
511,5,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
511,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
511,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
511,8,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
512,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
513,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
514,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
515,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
516,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
516,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
516,3,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
517,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
517,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
519,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
519,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
519,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
520,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
521,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
521,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
521,3,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
521,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
522,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
522,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
523,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
523,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
523,3,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
524,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
524,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
524,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
524,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
525,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
525,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
525,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,4,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
525,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
525,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
525,7,Periprosthetic fracture,Musculoskeletal procedural complications,Procedural related injuries and complications NEC,Inj&P,N
525,8,Sinusitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
526,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
526,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
527,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
527,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
528,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
529,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
529,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
529,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
529,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
529,5,Normochromic normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
529,6,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
529,7,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
530,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
530,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
530,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
530,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
530,5,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
530,6,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
530,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
530,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
530,9,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
530,10,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
530,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
530,12,Tongue biting,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
531,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
532,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
532,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
532,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
532,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
532,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
533,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
534,1,Deafness,Hearing losses,Hearing disorders,Ear,N
535,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
536,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
537,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
537,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
538,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
538,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
538,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
539,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
540,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
540,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
540,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
541,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
541,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
541,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
542,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
542,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
543,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
544,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
544,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
545,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
545,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
545,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
546,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
546,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
546,3,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
547,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
547,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
548,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
548,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
548,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
549,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
550,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
550,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
550,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
550,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
551,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,1,Antibiotic level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
553,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
553,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
554,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
554,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
555,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
556,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
557,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
558,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
559,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
559,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
559,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
559,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
559,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
559,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
560,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
561,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
561,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
562,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
562,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
563,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
564,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
565,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
566,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
566,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
567,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
567,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
567,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
568,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
568,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
568,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
568,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
568,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
569,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
570,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
571,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
572,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
573,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
573,2,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
573,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
574,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
575,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
575,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
575,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
575,4,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
575,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
576,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
577,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
577,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
577,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
578,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
578,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
579,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
580,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
580,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
580,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
580,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
580,5,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
580,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
580,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
580,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,Y
580,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
580,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
580,11,Mast cell degranulation present,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
580,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
580,14,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
580,15,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
580,16,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
580,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,18,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
581,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
582,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
583,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
583,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
584,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
585,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
586,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
587,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
588,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
589,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
589,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
590,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
591,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
592,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
593,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
593,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
594,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
595,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
596,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
597,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
597,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
597,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
597,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
597,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
598,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
599,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
599,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
600,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
601,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
601,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
602,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
602,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
602,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
602,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
603,1,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
603,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
603,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
604,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
604,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
605,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
606,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
607,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
607,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
607,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
608,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
608,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
608,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
609,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
610,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
610,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
610,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
611,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
612,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
612,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
613,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
613,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
614,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
614,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
614,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
614,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
614,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
615,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
616,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
617,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
618,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
618,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
618,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
618,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
618,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
619,1,Hand dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
620,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
621,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
621,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
622,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
623,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
624,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
624,2,Administration site induration,Administration site reactions NEC,Administration site reactions,Genrl,N
624,3,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
624,4,Administration site warmth,Administration site reactions NEC,Administration site reactions,Genrl,N
624,5,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
625,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
625,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
625,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
626,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
626,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
626,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
626,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
626,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
627,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
628,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
629,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
629,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
629,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
629,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
630,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
631,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
632,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
632,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
632,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
634,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
635,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
635,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
636,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
637,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
638,1,Clostridium bacteraemia,Clostridia infections,Bacterial infectious disorders,Infec,N
639,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
640,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
642,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
642,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
642,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
643,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
643,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
644,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
644,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
644,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
644,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
644,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
644,6,Headache,Headaches NEC,Headaches,Nerv,N
644,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
644,8,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
645,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
645,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
645,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
645,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
645,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
645,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
645,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
645,9,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
646,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
647,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
648,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
648,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
649,1,Acantholysis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
649,2,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
649,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
649,4,Bandaemia,Leukocytoses NEC,White blood cell disorders,Blood,N
649,5,Benign familial pemphigus,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
649,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
649,7,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
649,8,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
649,9,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
649,10,Oral mucosa erosion,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
649,11,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
649,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
649,13,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
649,14,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
649,15,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
649,16,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
650,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
650,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
651,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
651,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
652,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
653,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
654,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
655,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
655,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
655,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
655,4,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
655,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
655,6,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
655,7,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
655,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
655,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
655,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
655,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
655,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
655,14,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
655,15,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
655,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
655,17,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
655,18,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
655,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
655,20,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
656,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
656,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
657,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
657,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
657,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
657,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
658,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
659,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
660,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
660,2,Neonatal anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
661,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
661,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
662,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
663,1,Dose calculation error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
663,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
664,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
664,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
664,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
665,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
665,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
666,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
667,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
667,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
668,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
668,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
668,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
668,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
669,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
669,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
670,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
670,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
671,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
672,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
673,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
674,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
675,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
675,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
675,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
676,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
676,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
676,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
677,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
677,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
678,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
678,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
679,1,Candida endophthalmitis,Candida infections,Fungal infectious disorders,Infec,N
680,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
680,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
681,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
681,2,Dysbiosis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
681,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
681,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
681,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
682,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
682,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
682,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
683,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
684,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
684,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
684,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
685,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
686,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
686,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
687,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
687,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
688,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
689,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
690,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
690,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
690,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
690,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
690,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
691,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
691,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
692,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
692,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
693,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
693,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
693,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
693,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
694,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
695,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
695,2,Drug chemical incompatibility,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,3,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
696,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
697,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
698,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
699,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
700,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
701,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
701,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
702,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
702,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
702,3,Therapeutic drug monitoring analysis not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
703,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
704,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
705,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
706,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
706,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
707,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
708,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
708,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
709,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
710,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
711,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
712,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
713,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
713,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
714,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
715,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
715,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
716,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
717,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
718,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
718,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
718,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
718,4,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
719,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
719,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
719,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
719,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
719,5,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
720,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
721,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
722,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,2,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
722,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
722,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
722,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
722,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
722,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
722,8,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
723,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
723,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
724,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
724,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
725,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
725,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
726,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
727,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
728,1,Puerperal pyrexia,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
729,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
730,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
730,2,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
731,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
731,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
731,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
732,1,Puerperal pyrexia,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
733,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
733,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
733,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
733,5,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
734,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
735,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
736,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
737,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
737,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
737,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
738,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
739,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
739,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
739,3,Headache,Headaches NEC,Headaches,Nerv,N
739,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
739,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
740,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
741,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
741,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
742,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
742,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
742,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
743,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
743,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
743,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
744,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
745,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
745,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
745,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
746,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
747,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
748,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
749,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
750,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
751,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
752,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
752,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
753,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
753,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
754,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
756,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
757,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
757,2,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
757,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
757,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
757,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
757,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
757,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
757,8,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
758,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
758,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
759,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
760,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
761,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
761,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
761,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
761,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
762,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
762,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
762,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
762,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
762,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
763,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
764,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
765,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
765,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
765,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
765,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
765,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
766,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
766,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
766,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
766,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
766,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
766,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
766,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
767,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
768,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
769,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
769,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
770,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
770,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
771,1,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
772,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
772,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
772,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
773,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
773,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
773,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
774,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
775,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
775,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
775,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
776,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
776,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
776,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
776,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
776,5,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
776,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
776,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
777,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
778,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
778,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
778,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
778,4,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
779,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
779,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
780,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
780,2,Hyperthermia,Body temperature altered,Body temperature conditions,Genrl,N
781,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
782,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
782,2,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
783,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
783,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
783,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
784,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
785,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,Y
786,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
786,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
786,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
786,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
788,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
789,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
789,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
790,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
791,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
792,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
792,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
792,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
793,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
793,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
793,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
794,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
795,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
795,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
796,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
797,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
797,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
797,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
797,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
797,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
797,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
798,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
798,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
799,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
799,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
799,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
799,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
799,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
800,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
800,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
800,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
800,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
800,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
801,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
801,2,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
801,3,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
801,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
801,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
802,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
802,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
803,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
803,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
803,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
804,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
805,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
806,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
806,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
806,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
807,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
807,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
808,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
809,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
810,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
810,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
811,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
812,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
813,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
814,1,Deafness,Hearing losses,Hearing disorders,Ear,N
815,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
816,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
816,2,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
816,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
817,1,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
817,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
817,3,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
817,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
817,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
818,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
819,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
819,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
820,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
820,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
821,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
821,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
821,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
821,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,5,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
821,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
822,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
823,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
824,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,1,Candida endophthalmitis,Candida infections,Fungal infectious disorders,Infec,N
826,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
827,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
828,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
829,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
829,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
830,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
831,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
832,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
833,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
834,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
834,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
835,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
836,1,Circumoral swelling,Angioedemas,Angioedema and urticaria,Skin,N
836,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
836,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
836,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
836,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
837,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
838,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
839,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
840,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
840,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
840,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
841,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
841,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
842,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
842,2,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
843,1,Deposit eye,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
844,1,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
845,1,Deposit eye,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
846,1,Product closure issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
847,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
848,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
849,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
850,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
850,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
851,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
851,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
851,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
851,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
851,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
852,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
852,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
853,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
854,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
855,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
855,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
856,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
856,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
856,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
856,6,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
857,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
857,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
857,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
857,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
857,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
858,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
859,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
859,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
859,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
859,4,Weight decrease neonatal,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
860,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
860,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
861,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
862,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
863,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
864,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
865,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
866,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
867,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
867,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
867,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
867,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
868,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
869,1,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
870,1,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
871,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
872,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
873,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
874,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
875,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
875,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
876,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
877,1,Antimicrobial susceptibility test resistant,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
877,2,Drug dispensed to wrong patient,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
877,4,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
877,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
877,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
877,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
877,9,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
877,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
877,11,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,12,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,13,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
877,14,Therapeutic response delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
877,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
877,16,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,17,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,18,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
878,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
879,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
879,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
879,3,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
880,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
880,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
881,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
882,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
882,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
883,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
884,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,3,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
885,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
886,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
886,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
886,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,Y
886,4,Pneumonia pseudomonal,Pseudomonal infections,Bacterial infectious disorders,Infec,N
887,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
888,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
889,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
890,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
891,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
892,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
892,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
893,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
894,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
894,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
894,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
895,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
895,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
895,3,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
896,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
897,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
898,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
898,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
899,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
899,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
899,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
900,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
901,1,Bacillus infection,Bacillary infections,Bacterial infectious disorders,Infec,Y
902,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
902,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
902,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
903,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
903,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
904,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
905,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
905,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
906,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
906,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
907,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
907,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
908,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
909,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
910,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
911,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
912,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
912,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
913,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
914,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
915,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
916,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
917,1,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
917,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
918,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
919,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
919,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
919,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
919,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
920,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
920,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
921,1,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
921,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
921,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
921,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
921,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
922,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
922,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
922,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
922,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
923,1,Anaphylactoid shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
924,1,Aminoaciduria,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
924,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
924,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
925,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
925,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
926,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
926,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
927,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
927,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
927,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
927,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
927,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
927,6,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
927,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
928,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
929,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
930,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
930,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
930,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
931,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
931,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
931,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
931,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
931,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
931,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
932,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
933,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
934,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
936,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
937,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
937,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
937,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
938,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
939,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,1,Headache,Headaches NEC,Headaches,Nerv,N
940,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
940,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
941,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
941,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
941,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
941,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
941,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
941,6,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
942,1,Deafness,Hearing losses,Hearing disorders,Ear,N
942,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
943,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
945,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
945,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
945,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
945,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
945,5,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
945,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
945,7,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
945,8,Mitral valve prolapse,Mitral valvular disorders,Cardiac valve disorders,Card,N
945,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
945,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
945,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
945,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
946,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
946,2,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
946,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
946,4,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
946,5,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
947,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
947,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
948,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
948,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
949,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
950,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
950,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
951,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
951,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
952,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
953,1,Lactobacillus infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
953,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
953,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
954,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
955,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
955,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
955,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
956,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
957,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
958,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
959,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
959,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
960,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
962,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
962,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
963,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
964,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
964,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
964,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
964,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
965,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
965,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
966,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
967,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
969,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
970,1,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
971,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
972,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
972,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
973,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
974,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
975,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
976,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
976,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
976,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
977,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
977,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
977,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
978,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
979,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
979,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
980,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
980,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
980,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
981,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
982,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
983,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
984,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
985,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
985,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
986,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
986,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
987,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
987,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
988,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
